HCA Healthcare, Inc. (HCA)
NYSE: HCA · Real-Time Price · USD
431.92
-13.85 (-3.11%)
Apr 28, 2026, 4:00 PM EDT - Market closed
HCA Healthcare Analyst Ratings
Total Analysts
20
Consensus Rating
Buy
Price Target
$511.84
Upside
+18.50%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| TD Cowen | TD Cowen | Strong Buy Maintains $561 → $500 | Strong Buy | Maintains | $561 → $500 | +15.76% | Apr 27, 2026 |
| Barclays | Barclays | Buy Maintains $551 → $496 | Buy | Maintains | $551 → $496 | +14.84% | Apr 27, 2026 |
| RBC Capital | RBC Capital | Buy Maintains $593 → $534 | Buy | Maintains | $593 → $534 | +23.63% | Apr 27, 2026 |
| Wells Fargo | Wells Fargo | Hold Maintains $481 → $436 | Hold | Maintains | $481 → $436 | +0.94% | Apr 27, 2026 |
| Stephens & Co. | Stephens & Co. | Buy Maintains $560 → $530 | Buy | Maintains | $560 → $530 | +22.71% | Apr 27, 2026 |
| Keybanc | Keybanc | Buy Maintains $550 → $510 | Buy | Maintains | $550 → $510 | +18.08% | Apr 27, 2026 |
| Oppenheimer | Oppenheimer | Buy Maintains $540 → $520 | Buy | Maintains | $540 → $520 | +20.39% | Apr 27, 2026 |
| Truist Securities | Truist Securities | Strong Buy Maintains $546 → $535 | Strong Buy | Maintains | $546 → $535 | +23.87% | Apr 27, 2026 |
| TD Cowen | TD Cowen | Strong Buy Maintains $529 → $561 | Strong Buy | Maintains | $529 → $561 | +29.89% | Mar 10, 2026 |
| Mizuho | Mizuho | Buy Maintains $540 → $585 | Buy | Maintains | $540 → $585 | +35.44% | Feb 25, 2026 |
| UBS | UBS | Strong Buy Maintains $598 → $635 | Strong Buy | Maintains | $598 → $635 | +47.02% | Feb 23, 2026 |
| JP Morgan | JP Morgan | Hold Maintains $420 → $535 | Hold | Maintains | $420 → $535 | +23.87% | Feb 20, 2026 |
| Argus Research | Argus Research | Strong Buy Maintains $530 → $560 | Strong Buy | Maintains | $530 → $560 | +29.65% | Feb 6, 2026 |
| Wells Fargo | Wells Fargo | Hold Maintains $452 → $481 | Hold | Maintains | $452 → $481 | +11.36% | Jan 30, 2026 |
| Jefferies | Jefferies | Strong Buy Maintains $535 → $590 | Strong Buy | Maintains | $535 → $590 | +36.60% | Jan 28, 2026 |
| Oppenheimer | Oppenheimer | Buy Maintains $500 → $540 | Buy | Maintains | $500 → $540 | +25.02% | Jan 28, 2026 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.